Foresite Capital Management Vi LLC Xenon Pharmaceuticals Inc. Transaction History
Foresite Capital Management Vi LLC
- $178 Billion
- Q2 2025
A detailed history of Foresite Capital Management Vi LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Foresite Capital Management Vi LLC holds 160,000 shares of XENE stock, worth $6.27 Million. This represents 2.82% of its overall portfolio holdings.
Number of Shares
160,000Holding current value
$6.27 Million% of portfolio
2.82%Shares
1 transactions
Others Institutions Holding XENE
# of Institutions
221Shares Held
73.2MCall Options Held
336KPut Options Held
309K-
Avoro Capital Advisors LLC New York, NY5.4MShares$212 Million3.08% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.34MShares$170 Million1.31% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$141 Million6.91% of portfolio
-
Janus Henderson Group PLC London, X03.58MShares$140 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$125 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.44B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...